ETC
PTCT icon

Exchange Traded Concepts’s PTC Therapeutics PTCT Stock Holding History

Exchange Traded Concepts’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
26,334
+1,071
+4% +$77.3K 0.01% 695
2026
Q1 		$1.72M Buy
25,263
+23,718
+1,535% +$1.68M 0.01% 642
2025
Q4 		$117K Buy
1,545
+54
+4% +$3.92K ﹤0.01% 1340
2025
Q3 		$91.5K Buy
+1,491
New +$77.7K ﹤0.01% 1260

Other funds holding PTCT

BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Exchange Traded Concepts's PTCT Position: Q2 2026 in Review

Exchange Traded Concepts increased its PTC Therapeutics (PTCT) stake by 4.2% in Q2 2026, buying an estimated $77.3K and bringing the position to 26,334 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #695.

Exchange Traded Concepts first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. 55 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Exchange Traded Concepts held 26,334 shares of PTC Therapeutics worth $2.15M as of Q2 2026.
  • Exchange Traded Concepts bought 1,071 PTC Therapeutics shares in Q2 2026, an estimated $77.3K.
  • PTC Therapeutics made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #695 holding.
  • Exchange Traded Concepts first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 55 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.